Autoimmune Hemolytic Anemia After mRNA COVID Vaccine

Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatima, Zainab, Reece, Blair R. A., Moore, J. Suzanne, Means, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777324/
https://www.ncbi.nlm.nih.gov/pubmed/35045762
http://dx.doi.org/10.1177/23247096211073258
Descripción
Sumario:Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of a patient who developed immunoglobulin G (IgG)-mediated autoimmune hemolytic anemia (AIHA) after the Moderna COVID-19 messenger ribonucleic acid (mRNA) vaccine.

Ejemplares similares